期刊文献+

丙型肝炎病毒结构蛋白在痘苗病毒中的表达 被引量:3

Expression of hepatitis C viral structure protein by recombinant vaccinia virus
原文传递
导出
摘要 为研究中国丙型肝炎病毒(HCV)的抗原性及在细胞内的加工,将丙型肝炎病毒(HCV)5’非编码区(NTR)和结构基因(Core+E1+E2/NS1)插入痘苗病毒表达载体pJSA1175中,转染TK-143细胞,经纯化得到丙型肝炎(HCV)重组痘苗病毒vJSA1175CE株。Southernblot杂交表明,HCV结构基因存在于痘苗病毒之中。Westernblot分析发现,vJSA1175CE表达蛋白带位于90kDa,为一多聚蛋白;此蛋白为分泌型。 The hepatitis C viral (HCV) DNA fragment coding for the core and two glycoproteins E1+E2/NS1 were inserted into vaccinia virus vector pJSA1175, under the control of the promoter 7.5K. 143TK- cells transfected with the HCV recombinant plasmid pJSA1175CE in the presence of infectious TK+ vaccinia virus (Tiantan stain) yielded recombinant vaccinia virus and expressed a ~90kDa polyprotein. Southern blot hybridization showed that the inserted HCV cDNA was located at the vaccinia virus TK+ gene, J fragment. One polypeptide band between 106 and 80kDa was revealed in SDS-PAGE which reacted with anticore murine serum. The polypeptide could be secreted into the medium, the total amount was about the same as in the cells.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 1997年第4期340-343,共4页 Chinese Journal of Experimental and Clinical Virology
关键词 丙型肝炎病毒 痘苗病毒 基因表达 Hepatitis c virus Gene, viral Vaccinia virus Gene expression
  • 相关文献

参考文献1

  • 1阮力,病毒学报,1992年,8卷,101页

同被引文献41

  • 1王迪,张雪,杨复华,李文鑫.丙型肝炎病毒蛋白的分子生物学研究进展[J].中国病毒学,2004,19(5):526-530. 被引量:12
  • 2谭文杰,张柯,阮力.丙型肝炎病毒(HCV)实验性疫苗的研究进展[J].中国生物工程杂志,2006,26(10):64-70. 被引量:10
  • 3戚中田.丙型肝炎疫苗研究现状与方向[J].内科理论与实践,2007,2(4):241-244. 被引量:4
  • 4Rosen HR,Gretch DR.Hepatitis C virus:current understanding and prospects for future therapies.Mol Medi Today,1999,5:393-399.
  • 5Goto J,Nishinura S.Prevention of hepatitis C virus infection in a chimpanzees by vaccination and epitope mapping of antiserum directed against hyperirritable region 1.J Hepatol Res,2001,19:270-283.
  • 6Li W,Krishnadas DK,Kumar R,et al.Priming and stimulation of hepatitis C virus-specific CD4 + and CD8 + T cells against HCV antigens NS4, NS5a or NS5b from HCV-na? ve individuals:implications for prophylactic vaccine.Int lmmunol,2008,20:89-104.
  • 7Houghton M,Abrignani S.Prospects for a vaccine against the hepatitis C virus.Nature,2005,436:961-966.
  • 8Post JJ,Pan Y,Freemam A J,et at.Clearance of hepatitis C virus associated with cellular immunity in the absence of sera conversion in the hepatitis C incidence and transmission in prisons study cohort.J Infect Dis,2004,189:1846-1855.
  • 9Shimizu YK, Hijikata M. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses.J Viro,1994,68:1494.
  • 10Cenna J, Hunter M. Replication-deficient rabies virus-based vaccines are safe and immunagenic in mice and nonhuman primates.J Infect Dis,2009,200:1251-1260.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部